AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Navamedic

Report Publication Announcement Oct 28, 2024

3668_rns_2024-10-28_e57d8b12-310b-435a-a9d9-2e107153f1e6.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Navamedic ASA: Invitation to 2024 3rd quarter presentation

Navamedic ASA: Invitation to 2024 3rd quarter presentation

Oslo, October 28, 2024 - Navamedic ASA (OSE: Nava) will be presenting its 3rd

quarter 2024 results on Thursday, October 31st, 2024. The presentation will be

held at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. A link

to the webcast and the presentation will be available through the Navamedic web

site on the following link: https://navamedic.com/investors/financial -results/

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail: [email protected]

Lars Hjarrand, CFO, +47 917 62 842 E-mail: [email protected]

About Navamedic: Navamedic ASA is a full-service provider of high-quality

healthcare products to hospitals and pharmacies. Navamedic meets the specific

medical needs of patients and consumers by leveraging its highly scalable market

access platform, leading category competence and local knowledge. Navamedic is

present in all the Nordic countries, the Baltics and Benelux, with sales

representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway,

and listed on the Oslo Stock Exchange (ticker: NAVA). For more information,

please visit www.navamedic.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.